T-Cell Suppression By Src/ABL Kinase Inhibitors When Combined with Blinatumomab in Ph plus Acute Lymphoblastic Leukemia

被引：0

作者：

Leonard, Jessica ^{[1
]}

Kosaka, Yoko ^{[2
]}

Malla, Pavani ^{[3
]}

Hayes-Lattin, Brandon ^{[4
]}

Lamble, Adam J. ^{[5
]}

Druker, Brian J. ^{[1
]}

Tyner, Jeffrey W. ^{[6
]}

Chang, Bill H. ^{[3
]}

Lind, Evan F. ^{[7
]}

机构：

[1] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA

[2] Oregon Hlth & Sci Univ, Microbiol & Immunol, Portland, OR 97201 USA

[3] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR USA

[5] Seattle Childrens Hosp, Hematol Oncol, Seattle, WA USA

[6] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA

[7] Oregon Hlth & Sci Univ, Microbiol & Immunol, Portland, OR 97201 USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-119301

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2694

引用

页数：4

共 50 条

[1] Amplification of the ABL gene in T-cell acute lymphoblastic leukemia
Barber, KE
Martineau, M
Harewood, L
Stewart, M
Cameron, E
Strefford, JC
Rutherford, S
Allen, TD
Broadfield, ZJ
Cheung, KL
Harris, RL
Jalali, GR
Moorman, AV
Robinson, HM
Harrison, CJ
LEUKEMIA, 2004, 18 (06) : 1153 - 1156
[2] Amplification of the ABL gene in T-cell acute lymphoblastic leukemia
K E Barber
M Martineau
L Harewood
M Stewart
E Cameron
J C Strefford
S Rutherford
T D Allen
Z J Broadfield
K L Cheung
R L Harris
G R Jalali
A V Moorman
H M Robinson
C J Harrison
Leukemia, 2004, 18 : 1153 - 1156
[3] MODELING RESISTANCE TO TYROSINE KINASE INHIBITORS IN TEL/ABL plus ACUTE LYMPHOBLASTIC LEUKEMIA
Zimmermannova, O.
Zuna, J.
Machova, K.
Lizcova, L.
Zemanova, Z.
Falkenburg, J.
Harvey, R.
Chen, I. M.
Willman, C. L.
Trka, J.
Zaliova, M.
HAEMATOLOGICA, 2014, 99 : 271 - 272
[4] Potential for bispecific T-cell engagers: role of blinatumomab in acute lymphoblastic leukemia
Le Jeune, Caroline
Thomas, Xavier
DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 757 - 765
[5] ABL1 amplification in T-cell acute lymphoblastic leukemia
Bernasconi, P
Calatroni, S
Giardini, I
Inzoli, A
Castagnola, C
Cavigliano, PM
Rocca, B
Boni, M
Quarna, J
Zappatore, R
Caresana, M
Bianchessi, C
Pallavicini, EB
Lazzarino, M
CANCER GENETICS AND CYTOGENETICS, 2005, 162 (02) : 146 - 150
[6] The dual SRC-ABL inhibitors in Ph plus acute lymphoblastic leukemia to enhance synergy between targeted BCR-ABL and BCL-2 inhibitors.
Leonard, Jessica Taft
Spurgeon, Stephen Edward Forbes
Traer, Elie A.
Hayes-Lattin, Brandon M.
Loriaux, Marc
Tyner, Jeffrey
Druker, Brian J.
Chang, Bill H.
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
[7] CONTINUATION OF TYROSINE KINASE INHIBITORS AFTER CHEMOTHERAPY IN PH plus ACUTE LYMPHOBLASTIC LEUKEMIA
Smith, Stephanie
Aftandilian, Catherine
PEDIATRIC BLOOD & CANCER, 2019, 66
[8] Amplification of the ABL gene in T-cell acute lymphoblastic leukemia (T-ALL)
Bernasconi, P
Calatroni, S
Giardini, I
Inzoli, A
Cavigliano, PM
Boni, M
Motta, E
Rocca, B
Grassi, M
Bianchessi, C
Zappatore, R
Quarna, J
Caresana, M
Astori, C
Pallavicini, EB
Lazzarino, M
BLOOD, 2004, 104 (11) : 308A - 308A
[9] COMBINED T-CELL AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
HAEGERT, DG
CAWLEY, JC
KARPAS, A
GOLDSTONE, AH
BMJ-BRITISH MEDICAL JOURNAL, 1974, 4 (5936): : 79 - 82
[10] BCR-ABL rearrangement in adult T-cell acute lymphoblastic leukemia
Colleoni, GWB
Yamamoto, M
Kerbauy, J
Serafim, RC
Lindsey, CJ
Costa, FF
Grignolli, CRE
Saad, STO
AMERICAN JOURNAL OF HEMATOLOGY, 1996, 53 (04) : 277 - 278

← 1 2 3 4 5 →